Invasive cervical cancer incidence following quadrivalent human papillomavirus immunisation
Posted 22 May 2026
Dr Lisa Devine discusses a Swedish register-based study that investigated long-term risk of invasive cervical cancer following quadrivalent human papillomavirus vaccine, vaccine durability and population-level impact of vaccination programmes.
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.